United States Laboratory Automation Market 2026 : Industry Size to Reach USD 5,079.4 Million by 2034, At a CAGR of 5.71%

IMARC Group has recently released a new research study titled "United States Laboratory Automation Market Report by Type (Modular Automation, Whole Lab Automation), Equipment and Software Type (Automated Clinical Laboratory Systems, Automated Drug Discovery Laboratory Systems), End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes), and Region 2026-2034", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

Market Overview

The United States laboratory automation market reached a size of USD 3,081.0 Million in 2025. It is projected to grow at a CAGR of 5.71% during the forecast period from 2026 to 2034, reaching a value of USD 5,079.4 Million by 2034. Key factors driving this growth include technological innovations, increasing sample volumes, advancements in robotics, and a shortage of skilled personnel. The market is significantly influenced by regulatory frameworks and growing applications in clinical trials and biomedical research.

Study Assumption Years

● Base Year: 2025

● Historical Year/Period: 2020-2025

● Forecast Year/Period: 2026-2034

United States Laboratory Automation Market Key Takeaways

● The market size was USD 3,081.0 Million in 2025.

● The market is expected to grow at a CAGR of 5.71% from 2026 to 2034.

● The market forecast size is USD 5,079.4 Million by 2034.

● The ongoing advancements in medical infrastructure and increased healthcare expenditure stimulate market demand.

● Utilization of automation in clinical trials, drug discovery, and biomedical research significantly impacts growth.

● The market benefits from the Centers for Medicare & Medicaid Services (CMS) regulations under CLIA.

● Robotic systems are increasingly used to enhance efficiency and reduce human error.

Sample Request Link: https://www.imarcgroup.com/united-states-laboratory-automation-market/requestsample

United States Laboratory Automation Market Growth Factors

The growth of the United States laboratory automation market can be attributed to the increasing medical infrastructure improvement in the country and increasing healthcare expenditure in the United States. Furthermore, the increasing need to automate laboratories in clinical trials, drug discovery, and biomedical research has greatly contributed to the market's growth, because high throughput speed and accuracy are required.

For such demand, the regulating body is the Centers for Medicare & Medicaid Services (CMS), part of the United States Department of Health and Human Services. The Clinical Laboratory Improvement Amendments (CLIA) regulatory environment has promoted the demand for automation technology in laboratories by incentivizing laboratory-related human research.

The market is supported by labor shortages, along with improved automated technologies. In the U.S. as of 2024 there is a labor deficit of 70% and a shortage of 20,000 to 25,000 medical laboratory professionals. Automation provides a solution to this problem by automating repetitive processes, and improving the productivity of the workforce, while the use of robotics, AI and machine learning extends this range of applications.

Buy Report Now: https://www.imarcgroup.com/checkout?id=2538&method=1190

United States Laboratory Automation Market Segmentation

Breakup by Type:

● Modular Automation: Integrates individual standalone automation modules that can be combined and configured to meet specific laboratory needs, performing specific tasks and creating customized solutions.

● Whole Lab Automation: A comprehensive approach automating entire laboratory workflows as a cohesive system, streamlining multiple functions and processes.
Breakup by Equipment and Software Type:

● Automated Clinical Laboratory Systems: Includes workstations, Laboratory Information Management Systems (LIMS), sample transport systems, specimen handling systems, and storage retrieval systems. These systems focus on processing and analyzing patient samples for diagnostic and therapeutic purposes.

● Automated Drug Discovery Laboratory Systems: Comprises plate readers, automated liquid handling systems, LIMS, robotic systems, storage retrieval systems, and dissolution testing systems. These are designed to accelerate drug discovery and development workflows by managing large experimental data volumes.

Breakup by End User:

● Biotechnology and Pharmaceutical Companies: Automation is crucial for managing high-throughput screening processes to accelerate drug discovery.

● Hospitals and Diagnostic Laboratories: Increased diagnostic tests and patient sample volumes drive automation needs for efficiency.

● Research and Academic Institutes: Automation supports complex, high-throughput research tasks, enabling extensive experimentation and data collection.

Breakup by Region:

● Northeast
● Midwest
● South
● West

Regional Insights

The Northeast region is identified as a dominant market area due to its high concentration of academic institutions, research facilities, and biotechnology companies, particularly around Boston and New York City. This concentration propels demand for laboratory automation technologies dedicated to life sciences and pharmaceuticals. The South region also shows significant market growth driven by the biotechnology sector's expansion in cities like Houston and Raleigh, alongside rapid healthcare and diagnostic laboratory growth necessitating automation for managing patient volumes efficiently.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=2538&flag=C

Recent Developments & News

● June 2024: Alverno Laboratories, a major diagnostic testing service provider, integrated Ibex Medical Analytics' AI platform for cancer diagnostics within its laboratory network in Illinois and Indiana.

● May 2024: Olden Labs launched an automated animal research facility in the U.S. leveraging artificial intelligence, genetic engineering, and robotics.

● April 2024: Clarapath, a medical robotics company from New York, partnered with Mayo Clinic to advance laboratory automation in pathology laboratories.

Competitive Landscape

The market research report covers a comprehensive competitive landscape analysis including market structure, key player positioning, winning strategies, competitive dashboards, and company evaluation quadrants. Detailed profiles of all major companies have been provided.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302

This release was published on openPR.